GlassScriptPhysician profile
Sarah Bricker
NPI 1790397396
$2,248.28
in general payments reported to CMS, 2019-2025
21 companies · $569 in 2025
The $569 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.36 · 2023: $1,066 · 2024: $599 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,232 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,231.92 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $391.71 | 2023-2025 | Lifevest |
| Abiomed | $364.62 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $267.75 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Atricure, INC. | $154.28 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.73 | 2023 | Jardiance |
| Biosense Webster, INC. | $137.45 | 2024 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $137.02 | 2023 | Camzyos |
| Zoll Circulation INC | $103.00 | 2023 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Medtronic, INC. | $98.68 | 2025 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $57.19 | 2023 | Xarelto |
| Daiichi Sankyo INC. | $56.23 | 2023 | Injectafer |
| Boston Scientific Corporation | $52.51 | 2023 | Watchman Access System |
| Merck Sharp & Dohme LLC | $50.99 | 2023 | Verquvo |
| Zoll Respicardia, INC. | $46.49 | 2023-2024 | Remede System |
| Cvrx, INC. | $42.55 | 2023 | Barostim Neo System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $41.19 | 2023-2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $35.13 | 2023 | |
| Alnylam Pharmaceuticals INC. | $16.31 | 2023 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $15.12 | 2023 | Farxiga |
| Angiodynamics, INC. | $14.44 | 2024 | Auryon Laser System 100-120 Vac |
| Lexicon Pharmaceuticals, INC. | $13.89 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Bricker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.